Literature DB >> 23924538

[Citrate and renal stones].

Elisa E del Valle1, Francisco R Spivacow, Armando L Negri.   

Abstract

Citrate is a powerful inhibitor of the crystallization of calcium salts. Hypocitraturia is a biochemical common alteration in calcium stone formation in adults and especially in children. The acid pH (systemic, tubular and intracellular) is the main determinant of citrate excretion in the urine. While the etiology of hypocitraturia is idiopathic in most patients with kidney stones, there are a number of causes for this abnormality including distal renal tubular acidosis, hypokalemia, diets rich in animal protein and / or diets low in alkali and certain drugs, such as acetazolamide, topiramate, ACE inhibitors and thiazides. Dietary modifications that benefit these patients include high intake of fluids and fruits, especially citrus, sodium and protein restriction, with normal calcium intake. Treatment with potassium citrate is effective in patients with primary or secondary hypocitraturia and acidification disorders, which cause unduly acidic urine pH persistently. Adverse effects are low and are referred to the gastrointestinal tract. While there are various preparations of citrate (potassium citrate, sodium citrate, potassium citrate, magnesium) in our country is available only potassium citrate powder that is useful to correct both the hypocitraturia and the low urinary pH and reduce markedly the recurrence of kidney stones.

Entities:  

Keywords:  citrate; renal stones

Mesh:

Substances:

Year:  2013        PMID: 23924538

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  4 in total

1.  Enamel renal syndrome with associated amelogenesis imperfecta, nephrolithiasis, and hypocitraturia: A case report.

Authors:  Dhvani Bhesania; Ankit Arora; Sonali Kapoor
Journal:  Imaging Sci Dent       Date:  2015-09-09

2.  Safety of potassium-bearing citrate in patients with renal transplantation: A case report.

Authors:  Lin Wang; Yinglin Cui; Jianwei Zhang; Qinsheng Zhang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

3.  Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial.

Authors:  Carlos Torrecilla; Jaime Fernández-Concha; José R Cansino; Juan A Mainez; José H Amón; Simbad Costas; Oriol Angerri; Esteban Emiliani; Miguel A Arrabal Martín; Miguel A Arrabal Polo; Ana García; Manuel C Reina; Juan F Sánchez; Alberto Budía; Daniel Pérez-Fentes; Félix Grases; Antonia Costa-Bauzá; Jordi Cuñé
Journal:  BMC Urol       Date:  2020-06-05       Impact factor: 2.264

4.  Study of risk factor of urinary calculi according to the association between stone composition with urine component.

Authors:  Pan Wang; Hongxian Zhang; Jiansuo Zhou; Shangjia Jin; Chong Liu; Boxin Yang; Liyan Cui
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.